- Home
- CLDX vs OMCL Comparison
CLDX vs OMCL Comparison
Compare CLDX & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- OMCL
- Stock Information
- Founded
- CLDX N/A
- OMCL 1992
- Country
- CLDX United States
- OMCL United States
- Employees
- CLDX N/A
- OMCL 3590
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OMCL Computer Manufacturing
- Sector
- CLDX Health Care
- OMCL Technology
- Exchange
- CLDX Nasdaq
- OMCL Nasdaq
- Market Cap
- CLDX 1.2B
- OMCL 1.4B
- IPO Year
- CLDX 2008
- OMCL 2001
- Fundamental
- Price
- CLDX $19.44
- OMCL $31.07
- Analyst Decision
- CLDX Buy
- OMCL Buy
- Analyst Count
- CLDX 8
- OMCL 6
- Target Price
- CLDX $54.29
- OMCL $50.67
- AVG Volume (30 Days)
- CLDX 856.2K
- OMCL 592.2K
- Earning Date
- CLDX 05-05-2025
- OMCL 05-06-2025
- Dividend Yield
- CLDX N/A
- OMCL N/A
- EPS Growth
- CLDX N/A
- OMCL N/A
- EPS
- CLDX N/A
- OMCL 0.27
- Revenue
- CLDX $7,020,000.00
- OMCL $1,112,238,000.00
- Revenue This Year
- CLDX N/A
- OMCL $3.93
- Revenue Next Year
- CLDX N/A
- OMCL $4.41
- P/E Ratio
- CLDX N/A
- OMCL $110.81
- Revenue Growth
- CLDX 1.99
- OMCL N/A
- 52 Week Low
- CLDX $14.40
- OMCL $25.12
- 52 Week High
- CLDX $47.00
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- CLDX 54.30
- OMCL 38.24
- Support Level
- CLDX $17.45
- OMCL $29.30
- Resistance Level
- CLDX $20.36
- OMCL $31.70
- Average True Range (ATR)
- CLDX 1.21
- OMCL 1.58
- MACD
- CLDX 0.44
- OMCL 0.03
- Stochastic Oscillator
- CLDX 81.21
- OMCL 25.48
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.